Histocell SL - Product Pipeline Analysis, 2018 Update

Summary

Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex, medical devices, contract manufacturing and cell therapy programs, among others. Its wharton gel complex is a cosmetic ingredient with skin protective and regenerative properties. Histocell develops, manufactures and sells medical devices and drugs such as Cicatrigel, Histogel and Histobone, among others. The company also provides biocompatibility tests, advanced molecular and cellular biology analytical services and biological research services. Histocell is headquartered in Derio, Spain.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Histocell SL
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
Histocell SL Company Overview 4
Histocell SL Company Snapshot 4
Histocell SL Pipeline Products and Ongoing Clinical Trials Overview 4
Histocell SL Pipeline Analysis Overview 7
Histocell SL - Key Facts 7
Histocell SL - Major Products and Services 8
Histocell SL Pipeline Products by Development Stage 9
Histocell SL Pipeline Products Overview 12
Bioactive Wound Dressing 12
Bioactive Wound Dressing Product Overview 12
Biomaterial - Chronic Spinal Damage 13
Biomaterial - Chronic Spinal Damage Product Overview 13
Maxillofacial Implant 14
Maxillofacial Implant Product Overview 14
Peripheral Nerve Implant 15
Peripheral Nerve Implant Product Overview 15
Protein Based Bio-Scaffolds 16
Protein Based Bio-Scaffolds Product Overview 16
Reoxcare 17
Reoxcare Product Overview 17
Scaffold Regeneration - Oral Masticatory Mucosa Injuries 18
Scaffold Regeneration - Oral Masticatory Mucosa Injuries Product Overview 18
Histocell SL - Key Competitors 19
Histocell SL - Key Employees 20
Histocell SL - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 22
Histocell SL, Recent Developments 22
Mar 12, 2018: Histocell takes Part with Great Success in the 7th Seher Congress 22
Sep 26, 2017: Histocell and VITALVIA collaborate to promote the commercialisation in Spain of the new product for wound healing Reoxcare 22
Jun 20, 2016: Reoxcare: Luqas innovative wound dressing product, obtains CE mark in Europe 22
Appendix 24
Methodology 24
About GlobalData 27
Contact Us 27
Disclaimer 27

List Of Tables


Histocell SL Pipeline Products and Ongoing Clinical Trials Overview 4
Histocell SL Pipeline Products by Equipment Type 5
Histocell SL Pipeline Products by Indication 6
Histocell SL, Key Facts 7
Histocell SL, Major Products and Services 8
Histocell SL Number of Pipeline Products by Development Stage 9
Histocell SL Pipeline Products Summary by Development Stage 10
Bioactive Wound Dressing - Product Status 12
Bioactive Wound Dressing - Product Description 12
Biomaterial - Chronic Spinal Damage - Product Status 13
Biomaterial - Chronic Spinal Damage - Product Description 13
Maxillofacial Implant - Product Status 14
Maxillofacial Implant - Product Description 14
Peripheral Nerve Implant - Product Status 15
Peripheral Nerve Implant - Product Description 15
Protein Based Bio-Scaffolds - Product Status 16
Protein Based Bio-Scaffolds - Product Description 16
Reoxcare - Product Status 17
Reoxcare - Product Description 17
Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Status 18
Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Description 18
Histocell SL, Key Employees 20
Histocell SL, Joint Venture 21
Glossary 26

List Of Figures


Histocell SL Pipeline Products by Equipment Type 5
Histocell SL Pipeline Products by Development Stage 9

Histocell SL - Product Pipeline Analysis, 2018 Update

Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex,

USD 750 View Report

Histocell SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex,

USD 250 View Report

Allinky Biopharma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and

USD 250 View Report

Allinky Biopharma SL - Medical Equipment - Deals and Alliances Profile

Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available